One study, which used a specific ASO against murine TNF-α (ISIS 25302) at doses of 0.25, 2.5, and 12.5 mg/kg injected subcutaneously, reported a dose-dependent decrease in TNF-α mRNA expression in the colon and a decrease in the severity of chronic colitis. The gene discussed is TNF; the disease is Chronic colitis.